Boston Scientific ups stake in Aspect

Interventional device developer Boston Scientific of Natick, MA, has entered an agreement to purchase 500,000 shares of patient-monitoring device manufacturer Aspect Medical Systems, according to the company.

As of April, Boston Scientific owned approximately 19.6% of Aspect's outstanding common stock, and may purchase an additional 25% under the terms of a stock-purchase agreement entered into in August 2002.

Aspect has a strategic alliance with Boston Scientific to introduce new sedation-management technology to interventional and specialty medical procedure suites, including the gastrointestinal endoscopy suite, the interventional cardiology suite, and the interventional radiology suite, the company said.

By staff writers
April 9, 2004

Related Reading

Boston Scientific launches Sentinol, April 8, 2004

FDA approves Boston Scientific fibroids treatment, March 30, 2004

Boston Scientific, EndoTex complete enrollment, March 25, 2004

Boston Scientific gets FDA approval for Taxus, March 5, 2004

Boston Scientific to build intercontinental distribution center, March 4, 2004

Copyright © 2004

Page 1 of 180
Next Page